Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As GVHD Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS) | Publicación